Zhejiang Hisun Pharmaceutical, Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Hisun Pharmaceutical, Ltd. with three other
companies in this sector in China:
Joincare Pharmaceutical Group Industry Company Limited
sales of 10.78 billion Chinese Renmimbi [US$1.72 billion]
of which 99%
was Industry and Commerce),
Harbin Pharmaceutical Group Company Limited
(12.02 billion Chinese Renmimbi [US$1.91 billion]
of which 66%
was Medicine Trade), and
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
(11.12 billion Chinese Renmimbi [US$1.77 billion]
of which 96%
Zhejiang Hisun Pharmaceutical, Ltd. reported sales of 10.57 billion Chinese Renmimbi (US$1.68 billion)
December of 2017.
increase of 8.6%
versus 2016, when the company's sales were 9.73 billion Chinese Renmimbi.
Sales of Other, Main Operations saw an increase
that was more than double the company's growth rate: sales were up
11,549.4% in 2017, from
6,837.61 Chinese Renmimbi to 796,537.13 Chinese Renmimbi.
Zhejiang Hisun Pharmaceutical, Ltd. also saw significant increases in sales in
Other Operations (up 40.6% to 227.26 million Chinese Renmimbi)